Screening
Screening for bladder cancer is not standard practice, but studies among populations with known risk factors suggest there may be a survival benefit.[16][38][51]
US National Comprehensive Cancer Network guidelines recommend considering germline genetic testing for patients who present at a younger age or with a personal or family history of a Lynch syndrome-related cancer (e.g., colorectal, endometrial, gastric, ovarian, pancreatic).[44]
Use of this content is subject to our disclaimer